Evoke Pharma Schedules Webcast and Conference Call for Third Quarter 2016 Financial Results
November 01 2016 - 8:30AM
Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical
company focused on treatments for gastrointestinal (GI) diseases,
today announced that it will issue its financial results for the
third quarter 2016 on Wednesday, November 9, 2016, after the close
of the market.
Evoke will hold a conference call on November 9, 2016, at 4:30
p.m. ET to discuss the results. The dial-in numbers are
1-877-407-0789 for domestic callers and 1-201-689-8562 for
international callers. The conference ID number for both is
13648936. A live webcast of the conference call will also be
available on the investor relations page of the Company's corporate
website at www.EvokePharma.com.
After the live webcast, the event will remain archived on
Evoke’s website for one year. In addition, a telephonic replay of
the call will be available until November 16, 2016. The replay
dial-in numbers are 1-844-512-2921 for domestic callers and
1-412-317-6671 for international callers. Please use event passcode
13648936.
About Evoke Pharma, Inc.
Evoke is a specialty pharmaceutical company focused
primarily on the development of drugs to treat GI disorders and
diseases. The Company is developing Gimoti, a metoclopramide nasal
spray for the relief of symptoms associated with acute and
recurrent gastroparesis in women with diabetes mellitus. Diabetic
gastroparesis is a GI disorder afflicting millions of sufferers
worldwide, in which the stomach takes too long to empty its
contents resulting in serious digestive system symptoms.
Metoclopramide is the only product currently approved in the United
States to treat gastroparesis, and is currently available only in
oral and intravenous forms. Gimoti is a novel formulation of this
drug, designed to provide systemic delivery of metoclopramide
through nasal administration. Visit www.EvokePharma.com for
more information.
Investor Contact:
The Ruth Group
David Burke
O: 646-536-7009
C: 917-618-2651
dburke@theruthgroup.com
Evoke Pharma (NASDAQ:EVOK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Evoke Pharma (NASDAQ:EVOK)
Historical Stock Chart
From Apr 2023 to Apr 2024